Schedule 13G ownership disclosure

TONIX PHARMACEUTICALS HOLDIN

Security class unavailable · CUSIP: 890260706

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-21-002126
Form type
SC 13G/A
Filer
Altium Capital Management LLC
CIK
CIK 1746382
Filed
Feb 11, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub